股票 › PEN
彭布拉医疗 PEN
$319.21 −$1.90 (-0.59%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $319.00 -0.07%
开盘$319.03
昨收$321.11
当日区间$319.03 – $320.72
成交量336.7K
市值$12.58B
市盈率（TTM）80.4
股息率–
PEN 相关新闻
匹配 Penumbra 或代码 PEN 的头条新闻，按最新排序。
- Le Pen, who has consistently advocated for dialogue with Russia, issued a rare condemnation this time.
- Eisai: The subcutaneous formulation of the early-stage Alzheimer's disease treatment "Rekembi," the "Rekembi Subcutaneous Injection 250 mg Pen," has received approval in Japan. 正面
- CCORF Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $374
- Wells Fargo Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $374
- RBC Capital Initiates Penumbra(PEN.US) With Hold Rating, Announces Target Price $374
- Citi Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $350
- Evercore Maintains Penumbra(PEN.US) With Buy Rating, Cuts Target Price to $320 负面
- RBC Capital Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $374
- Citi Maintains Penumbra(PEN.US) With Hold Rating, Cuts Target Price to $350 负面
- Evercore Maintains Penumbra(PEN.US) With Buy Rating, Cuts Target Price to $335 负面
- Citi Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $374
- Evercore Maintains Penumbra(PEN.US) With Buy Rating, Cuts Target Price to $345 负面
- Penumbra: Penumbra, Inc. (Election Merger) - Anticipated Adjustment Option Symbol: PEN New Symbol: BSX1
- Sailor Pen: Notice Regarding Financial Information of Non-Listed Parent Companies, etc.
- Sailor Pen: Matters concerning controlling shareholders, etc.
暂无评论——快来第一个聊聊 PEN。